Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Novo business and prospects, resulting in its stock trading at inflated prices.
Investors who lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO
06:31pm, Friday, 24'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz
06:16pm, Friday, 24'th Jan 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk's recent climb.
Class Action Filed Against Novo Nordisk A/S (NVO) Seeking Recovery for Investors - Contact Levi & Korsinsky
06:00pm, Friday, 24'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws
SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Novo Nordisk A/S (NYSE: NVO) securities between November 2, 2022 and December 19
The Score: Novo Nordisk, Oracle, Netflix, and More Stocks That Defined the Week
04:32pm, Friday, 24'th Jan 2025
Here are some of the major companies whose stocks moved on the week's news.
Stock Market Today: Stocks Slip as Inflation Worries Rise
04:06pm, Friday, 24'th Jan 2025
Concerns over price pressures are growing ahead of next week's Fed meeting.
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Novo Nordisk
Novo Nordisk shares surge on positive weight loss drug trial results
11:41am, Friday, 24'th Jan 2025
Novo Nordisk (NYSE:NVO) stock added more than 7% on Friday after the Danish drugmaker unveiled positive early-stage trial results for its weight loss drug amycretin. The trial demonstrated that patien
Why Novo Nordisk Stock Jumped a Lucky 7.7% Today
11:38am, Friday, 24'th Jan 2025
Finally, some good news for Novo Nordisk (NVO 7.30%) shareholders!
Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results
10:20am, Friday, 24'th Jan 2025
Novo Nordisk's (NVO) U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.
Pharma Stock Pops on Upbeat Obesity Drug Trial Results
10:10am, Friday, 24'th Jan 2025
Novo Nordisk A/S (NYSE:NVO) today announced positive early-stage trial results for its amycretin obesity drug.
BA's $3.5B Loss, NVO Weight Loss Drug Trial, AXP Down on Strong Earnings
10:06am, Friday, 24'th Jan 2025
"It's difficult to find what we're not liking" for American Express's (AXP) earnings, says Jenny Horne. A strong report bolstered by a big holiday shopping season wasn't enough to impress investors.
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 24'th Jan 2025
Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
S&P500: Futures Hold Steady as Twilio and Novo Nordisk Steal the Spotlight
09:34am, Friday, 24'th Jan 2025
S&P 500 futures steady after record highs. Novo Nordisk and Twilio surge, while Boeing posts $4B loss.
